Published in Int J Colorectal Dis on April 21, 2010
Simple technique for gasless transumbilical single-incisional laparoscopic-assisted appendectomy. Langenbecks Arch Surg (2014) 2.00
Abdominal wall-lifting versus CO2 pneumoperitoneum in laparoscopy: a review and meta-analysis. Int J Clin Exp Med (2014) 0.78
Gasless single-incision laparoscopic inguinal hernia repair: initial experience. Hernia (2017) 0.75
A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med (2004) 19.45
Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet (2005) 14.64
Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet (2002) 14.34
Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA (2002) 6.21
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet (2004) 4.65
Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg (2006) 3.10
Short-term outcomes of the Australasian randomized clinical study comparing laparoscopic and conventional open surgical treatments for colon cancer: the ALCCaS trial. Ann Surg (2008) 2.50
Randomized clinical trial of laparoscopic versus open abdominal rectopexy for rectal prolapse. Br J Surg (2002) 1.61
Effect of laparoscopy on immune function. Br J Surg (2001) 1.60
Hepatic and portal vein blood flow during carbon dioxide pneumoperitoneum for laparoscopic hepatectomy. Surg Endosc (1998) 1.55
Hemodynamic and pulmonary changes during open, carbon dioxide pneumoperitoneum and abdominal wall-lifting cholecystectomy. A prospective, randomized study. Surg Endosc (2000) 1.43
Port site metastases and recurrence after laparoscopic colectomy. A randomized trial. Surg Endosc (1998) 1.42
Laparoscopically assisted colon resection for colon carcinoma: perioperative results and long-term outcome. Surg Endosc (2000) 1.32
Port site recurrences after laparoscopic surgery. A review. Dig Surg (1998) 1.30
Systemic acute-phase response after laparoscopic and open cholecystectomy. Surg Endosc (2001) 1.30
Cellular and humoral inflammatory response after laparoscopic and conventional colorectal resections. Surg Endosc (2001) 1.26
Cardiovascular changes during laparoscopic cholecystectomy. Surg Gynecol Obstet (1992) 1.25
Stress response to laparoscopic surgery: a review. Surg Endosc (2004) 1.22
Increased tumor growth and spread after laparoscopy vs laparotomy: influence of tumor manipulation in a rat model. Surg Endosc (1999) 1.22
Laparoscopic-assisted vs. open surgery for colorectal cancer: comparative study of immune effects. Dis Colon Rectum (1998) 1.19
Systemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum (2003) 1.18
Incidence of port site recurrence after laparoscopic cholecystectomy for preoperatively unsuspected gallbladder carcinoma. Surgery (1998) 1.15
Pneumoperitoneum with carbon dioxide stimulates growth of malignant colonic cells. Surgery (1997) 1.10
Gasless laparoscopy may reduce the risk of port-site metastases following laparascopic tumor surgery. Arch Surg (1997) 1.04
The effects of elevated intraabdominal pressure, hypercarbia, and positioning on the hemodynamic responses to laparoscopic colectomy in pigs. Surg Endosc (1998) 1.02
Prospective evaluation of laparoscopy-assisted colectomy versus laparotomy with resection for management of complex polyps of the sigmoid colon. World J Surg (2002) 0.99
Hypercarbia during carbon dioxide gas insufflation for therapeutic laparoscopy: a note of caution. Surg Laparosc Endosc (1992) 0.95
A safe and simple method to maintain a clear field of vision during laparoscopic cholecystectomy. Surg Endosc (1992) 0.93
Gasless laparoscopy and conventional instruments. The next phase of minimally invasive surgery. Arch Surg (1993) 0.93
Gasless laparoscopic-assisted ileostomy or colostomy closure using an abdominal wall-lifting device. Surg Endosc (2001) 0.91
Laparoscopy. Gasless vs. CO2 pneumoperitoneum. J Reprod Med (1997) 0.87
CO2 environment influences the growth of cultured human cancer cells dependent on insufflation pressure. Surg Endosc (2000) 0.87
Abdominal wall lift versus carbon dioxide insufflation for laparoscopic resection of ovarian tumors. J Clin Anesth (1999) 0.86
Haemodynamic changes in patients undergoing laparoscopic cholecystectomy: measurement by transthoracic electrical bioimpedance. Br J Anaesth (1993) 0.86
Systemic stress responses after laparoscopic or open hernia repair. Eur J Surg (2000) 0.86
Pneumoperitoneum augmented tumor invasiveness is abolished by matrix metalloproteinase blockade. Surg Endosc (2001) 0.85
Gasless laparoscopic surgery using a new intra-abdominal fan retractor system: an experience of 500 cases. J Nippon Med Sch (2005) 0.85
Gasless laparoscopic surgery for ulcerative colitis and familial adenomatous polyposis:initial experience of 7 cases. Surg Endosc (2003) 0.83
Intraperitoneal tumor growth is influenced by pressure of carbon dioxide pneumoperitoneum. Surg Endosc (2000) 0.81
Comparison of the hemodynamic effects of gasless abdominal distention and CO2 pneumoperitoneum during incremental positive end-expiratory pressure. J Surg Res (1995) 0.79
Gasless laparoscopy-assisted colorectal surgery. Surg Endosc (2001) 0.78
In vivo real-time analysis of intraperitoneal radiolabeled tumor cell movement during laparoscopy. Dis Colon Rectum (1999) 0.75
A prospective comparison of laparoscopic exposure techniques for rectal mobilization and sigmoid resection. J Am Coll Surg (1997) 0.75
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist (2007) 1.85
Pneumothorax after bevacizumab-containing chemotherapy: a case report. Jpn J Clin Oncol (2010) 1.62
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol (2005) 1.55
Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism. J Cancer Res Clin Oncol (2014) 1.49
Comments on the non-invasive measurement of bladder pressure developed by Pel et al. Neurourol Urodyn (2004) 1.39
F-18 FDG PET/CT in evaluation of pulmonary sclerosing hemangioma. Clin Nucl Med (2011) 1.24
Rectal perforation: a life-threatening complication of stapled hemorrhoidectomy: report of a case. Dis Colon Rectum (2003) 1.23
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma. Cancer (2008) 1.20
Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Colorectal Dis (2011) 1.17
Expression of beta-F1-ATPase and mitochondrial transcription factor A and the change in mitochondrial DNA content in colorectal cancer: clinical data analysis and evidence from an in vitro study. Int J Colorectal Dis (2008) 1.16
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol (2010) 1.16
Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer (2006) 1.16
Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. Clin Cancer Res (2007) 1.10
Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis (2011) 1.09
How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum (2005) 1.08
Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum (2005) 1.08
Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res (2005) 1.08
Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology (2005) 1.06
TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer. J Biol Chem (2011) 1.05
Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. Cancer Sci (2009) 1.04
Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization. Genes Chromosomes Cancer (2005) 1.04
Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum (2008) 1.04
CIP2A is a predictor of poor prognosis in colon cancer. J Gastrointest Surg (2012) 1.03
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery. Radiat Oncol (2013) 1.02
Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol (2011) 1.01
SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann Surg Oncol (2009) 1.00
ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma. Cancer Sci (2009) 1.00
Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis (2009) 1.00
Long-term prognosis of patients with obstructing carcinoma of the right colon. Am J Surg (2004) 0.99
Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis (2007) 0.99
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. J Surg Oncol (2012) 0.99
Diffuse reflectance spectroscopy detects increased hemoglobin concentration and decreased oxygenation during colon carcinogenesis from normal to malignant tumors. Opt Express (2009) 0.99
CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology (2002) 0.98
Attenuation correction of PET images with interpolated average CT for thoracic tumors. Phys Med Biol (2011) 0.96
Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol (2004) 0.95
Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma. World J Gastroenterol (2005) 0.95
Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. J Surg Res (2003) 0.95
Loss of heterozygosity: an independent prognostic factor of colorectal cancer. World J Gastroenterol (2005) 0.94
Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution. Am J Surg (2011) 0.94
IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines. J Interferon Cytokine Res (2004) 0.92
The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol (2010) 0.92
Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis (2006) 0.92
Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis (2010) 0.91
The impact of patent eligibility on biotech patents: A flow chart for determining patent eligibility and an immune therapy case study. Hum Vaccin Immunother (2015) 0.91
Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J Affect Disord (2010) 0.91
Association of C-reactive protein gene polymorphisms and colorectal cancer. Ann Surg Oncol (2011) 0.91
The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg (2013) 0.90
Retained rectal foreign bodies. J Chin Med Assoc (2003) 0.90
Prospective study of the functional results of transanal endoscopic microsurgery. Hepatogastroenterology (2003) 0.90
Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells. Biochem Biophys Res Commun (2011) 0.89
Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Ann Thorac Surg (2009) 0.89
Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model. Nucl Med Biol (2008) 0.89
Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute. Int J Colorectal Dis (2009) 0.89
Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan. J Biomed Sci (2011) 0.89
The impact of family history on the outcome of patients with colorectal cancer in a veterans' hospital. Int J Colorectal Dis (2009) 0.89
The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer. J Gastrointest Surg (2011) 0.88
Clinicopathologic features and prognostic analysis of MSI-high colon cancer. Int J Colorectal Dis (2011) 0.88
Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents. Cancer Lett (2013) 0.88
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. Int J Oncol (2005) 0.87
Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism. Clin Nucl Med (2003) 0.87
Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. J Clin Virol (2012) 0.87
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study. Support Care Cancer (2011) 0.87
In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab. Menopause (2013) 0.87
The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer. J Surg Oncol (2014) 0.86
Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors. Ann Surg Oncol (2014) 0.86
Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers. Surgery (2009) 0.85
p53 protein accumulation as a prognostic marker in sporadic colorectal cancer. Int J Colorectal Dis (2006) 0.85
Comparison between straight and J-pouch coloanal anastomoses in surgery for rectal cancer. Surg Today (2002) 0.84
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET. Ann Nucl Med (2008) 0.84
Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery. World J Surg (2004) 0.84
Influence of pneumoperitoneum on tumor growth and pattern of intra-abdominal tumor spreading: in vivo study of a murine model. Hepatogastroenterology (2008) 0.84
Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases. Int J Colorectal Dis (2010) 0.83